FOXO1 and pulmonary arterial hypertension: FoxO1 expression is downregulated in the pulmonary vasculature and PASMCs of patients with PAH, and reconstitution of FoxO1 activity reverses vascular remodeling and right ventricular hypertrophy in vitro (54).